Starpharma Holdings Limited has released a press release.
Successful Completion of $32 million Entitlement Offer
Earlier from Starpharma
- Entitlement Offer Investor Presentation
- DEP milestone triggers partner option fee
- Positive DEP HER2-Lu preclinical data support Phase 1 entry
- FDA confirms path to DEP HER2 first-in-human study